Dr. Gulati is an Assistant Professor of Medicine in the Division of Hematology and Oncology at the University of California Davis School of Medicine and UC Davis Comprehensive Cancer Center, where she cares for patients with kidney cancer and other genitourinary malignancies. She completed her Hematology/ Oncology fellowship training at University of Cincinnati (UC), following which she completed an Internal Medicine Scholarly Training for Academic Research (IMSTAR) fellowship, during which she completed a Master of Science (MSc) and attended the ASCO/ AACR Methods of Clinical Research Workshop at Vail. As a clinician investigator with an interest in translational research, specifically pertaining to patients with renal cell carcinoma (RCC), she was initially a KL2 scholar supported by the Center for Clinical and Translational Science and Training (CCTST) at UC and subsequently received a K08 grant from the National Cancer Institute (NCI). Dr. Gulati’s research aims to gain a better understanding of the metabolic reprogramming that occurs during progression in clear cell renal cell carcinoma (ccRCC), and she seeks to define a specific “metabolic phenotype” that would be capable of surviving in metastatic tumor microenvironments using live cell analysis and spatial transcriptomics. Through these efforts, Dr. Gulati hopes to provide a deep understanding of tumor heterogeneity and dysregulated tumor metabolism in ccRCC. In addition to utilizing these techniques to define prognosis, she will be able to nominate new therapeutic approaches for tumors that enrich for specific pathways, thus paving the path for future clinical trials.